Cargando…

TBIO-05. GENOME-SCALE NUCLEOTIDE-SPECIFIC CHARACTERIZATION OF 5-HYDROXYMETHYLCYTOSINE IN PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS

Though aberrant cytosine modifications are prevalent in cancer, nucleotide-specific 5-hydroxymethylcytosine (5hmC) modifications remain understudied, including in pediatric CNS tumors. Brain 5-hydroxymethylation is linked with development and differentiation. We measured genome-scale nucleotide-spec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Azizgolshani, Nasim, Petersen, Curtis L, Salas, Lucas, Chen, Youdinghuan, Perreard, Laurent, Nguyen, Lananh N, Christensen, Brock C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Tumor Biology (not fitting a specific disease category)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715137/ http://dx.doi.org/10.1093/neuonc/noaa222.833

Ejemplares similares

TBIO-03. Angiogenesis in Pituitary Adenoma
por: Yoshida, Daizo, et al.
Publicado: (2022)

TBIO-12. THE SPECTRUM OF MITOCHONDRIAl DNA (mtDNA) MUTATIONS IN PEDIATRIC CENTRAL NERVOUS SYSTEM (CNS) TUMORS
por: Kaneva, Kristiyana, et al.
Publicado: (2020)

DNA 5-hydroxymethylcytosine in pediatric central nervous system tumors may impact tumor classification and is a positive prognostic marker
por: Azizgolshani, Nasim, et al.
Publicado: (2021)

TBIO-27. RASOPATHIES AND BRAIN TUMOROGENESIS: ARE SOS1 MUTATIONS ARE CONCERNED?
por: Abdelmoula, Nouha Bouayed, et al.
Publicado: (2020)

TBIO-09. EZHIP is not expressed within the developing mouse or human brain
por: Talal Younes, Subhi, et al.
Publicado: (2022)

TBIO-01. SEX DIFFERENCES IN REDOX STATE UNDERLIE GLUTAMINE DEPENDENCY IN MALE GLIOBLASTOMA
por: Sponagel, Jasmin, et al.
Publicado: (2020)

TBIO-18. ESTABLISHING A PIPELINE FOR INDIVIDUALIZED TREATMENT OPTIONS FOR PEDIATRIC BRAIN CANCER
por: Djirackor, Luna, et al.
Publicado: (2020)

TBIO-24. USING MOLECULAR GUIDED THERAPY IN PEDIATRIC NEURO ONCOLOGY PATIENTS: THE SUCCESS AND BARRIERS
por: Armstrong, Beth, et al.
Publicado: (2020)

TBIO-19. INTEGRATED GENOMIC, PROTEOMIC AND PHOSPHOPROTEOMIC ANALYSIS OF SEVEN TYPES OF PEDIATRIC BRAIN CANCER
por: Petralia, Francesca, et al.
Publicado: (2020)

TBIO-06. BDNF-TRKB SIGNALING REGULATES NEURON-GLIOMA SYNAPTOGENESIS AND PROMOTES TUMOR PROGRESSION
por: Taylor, Kathryn, et al.
Publicado: (2020)

TBIO-02. Mapping the origins of pediatric brain tumors to cell type lineages in the developing cerebellum.
por: Okonechnikov, Konstantin, et al.
Publicado: (2022)

TBIO-01. Mutation Profiling of Paediatric Solid Tumours in a Cohort of South African Patients
por: Lamola, Lindiwe, et al.
Publicado: (2022)

TBIO-07. Pediatric tumor classification through genome-wide methylation profiling of extracellular vesicle DNA
por: Ricklefs, Franz, et al.
Publicado: (2022)

TBIO-26. NON-CANONICAL OPEN READING FRAMES ENCODE FUNCTIONAL PROTEINS ESSENTIAL FOR CANCER CELL SURVIVAL
por: Prensner, John, et al.
Publicado: (2020)

TBIO-13. USE OF NEXT GENERATION SEQUENCING TO IDENTIFY MOVE DRIVERS OF CRYPTIC, CLINICALLY AGGRESSIVE BRAIN TUMORS
por: Younes, Subhi Talal, et al.
Publicado: (2020)

TBIO-17. INTEGRATIVE ANALYSES OF BRAFv600e MUTATED GLIOMAS: FROM MOLECULAR BIOLOGY TO RADIOLOGY AND TREATMENTS
por: Lhermitte, Benoit, et al.
Publicado: (2020)

TBIO-14. CHARACTERISATION OF THE ARGININE PATHWAY ENZYMES IN PAEDIATRIC BRAIN TUMOURS TO DETERMINE SUSCEPTIBILITY TO THERAPEUTIC ARGININE DEPLETION
por: Bishop, Eleanor, et al.
Publicado: (2020)

TBIO-12. Screening for Cancer Predisposition Syndromes in Pediatric Neuro-Oncology Patients: a Single Institution Experience
por: Johns, Claire, et al.
Publicado: (2022)

TBIO-03. THE GIFT FROM A CHILD PROGRAM IS EMPOWERING POST-MORTEM TISSUE DONATION ACROSS THE UNITED STATES
por: Waanders, Angela, et al.
Publicado: (2020)

TBIO-09. IN SILICO ANALYSIS IDENTIFIES A PUTATIVE CELL-OF-ORIGIN FOR BRAF FUSION-POSITIVE CEREBELLAR PILOCYTIC ASTROCYTOMA
por: Younes, Subhi Talal
Publicado: (2020)

TBIO-15. MODELING DEVELOPMENTAL GENE EXPRESSION DYNAMICS AT CELLULAR RESOLUTION TO INTERPRET PEDIATRIC BRAIN TUMOR TRANSCRIPTIONAL PROGRAMS
por: Jessa, Selin, et al.
Publicado: (2020)

TBIO-16. NOTCH1 PATHWAY AS TARGET FOR DRUG INTERVENTION FOR HISTONE 3 G34R MUTATED pHGG
por: Foot, Katie, et al.
Publicado: (2020)

TBIO-11. DEEP LEARNING-BASED SINGLE-CELL RNA SEQUENCING DIFFERENTIATION IDENTIFIES SIMPLE AND COMPLEX TRANSCRIPTIONAL NETWORKS FOR SUBPOPULATION CLASSIFICATION
por: Prince, Eric, et al.
Publicado: (2020)

TBIO-07. SINGLE-CELL TRANSCRIPTOMIC PROFILE REVEALS MACROPHAGE HETEROGENEITY IN SONIC-HEDGEHOG MEDULLOBLASTOMA AND THEIR DISTINCT RESPONSES TO DIFFERENT TREATMENT MODALITIES
por: Dang, Mai, et al.
Publicado: (2020)

TBIO-02. IMMUNE PROFILING OF RARE EMBRYONAL BRAIN TUMORS REVEAL EVIDENCE OF DYSREGULATED INTERFERON SIGNALLING AS A POTENTIAL DETERMINANT OF IMMUNOLOGICAL HETEROGENEITY
por: Popovski, Dean, et al.
Publicado: (2020)

TBIO-08. BASE-RESOLUTION METHYLOMES OF GLIOMAS BEARING HISTONE H3.3 MUTATIONS REVEAL A G34 MUTANT-SPECIFIC SIGNATURE SHARED WITH BONE TUMORS
por: Sangatsuda, Yuhei, et al.
Publicado: (2020)

TBIO-21. Lnc-TALC PROMOTES O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE EXPRESSION VIA REGULATING THE C-MET PATHWAY BY COMPETITIVELY BINDING WITH miR-20b-3p
por: Wu, Pengfei, et al.
Publicado: (2020)

Hydroxymethylation alterations in progenitor-like cell types of pediatric central nervous system tumors are associated with cell type-specific transcriptional changes
por: Lee, Min Kyung, et al.
Publicado: (2023)

OTHR-16. Nutritional screening of U.S. pediatric central nervous system tumor survivors
por: Soja, Jacqueline, et al.
Publicado: (2022)

OTHR-02. MULTIMODALITY TREATMENT FOR CHILDREN WITH CENTRAL NERVOUS SYSTEM (CNS) TUMOR IN OUR INSTITUTE
por: Sasano, Mari, et al.
Publicado: (2020)

OTHR-05. A LIVING EX VIVO PLATFORM FOR FUNCTIONAL, PERSONALIZED PEDIATRIC BRAIN CANCER DIAGNOSIS
por: Mann, Breanna, et al.
Publicado: (2023)

OTHR-11. The effects of the COVID-19 Pandemic on the time to diagnosis in pediatric patients with Primary central nervous system tumors
por: Canova, Tyler, et al.
Publicado: (2022)

OTHR-06. Knowledge gap among health care providers in childhood central nervous system tumors: Result from an international multicenter survey
por: Rajagopal, Revathi, et al.
Publicado: (2022)

MethylSPWNet and MethylCapsNet: Biologically Motivated Organization of DNAm Neural Networks, Inspired by Capsule Networks
por: Levy, Joshua J., et al.
Publicado: (2021)

SPINAL TUMORS-05 CERVICAL DENDRITIC FOLLICULAR SARCOMA: ABOUT A CASE WITH LITERATURE REVIEW
por: Mala, Zeus, et al.
Publicado: (2023)

OTHR-13. IDENTIFYING INDIVIDUALS WITH PRIMARY CENTRAL NERVOUS SYSTEM TUMORS AT RISK FOR HEREDITARY CANCER SYNDROMES USING A STATEWIDE CANCER REGISTRY
por: Whipple, Nicholas, et al.
Publicado: (2023)

Tumor type and cell type-specific gene expression alterations in diverse pediatric central nervous system tumors identified using single nuclei RNA-seq
por: Lee, Min Kyung, et al.
Publicado: (2023)

OTHER-05 THE CHALLENGES IN MANAGING CHILDREN WITH PRIMARY CENTRAL NERVOUS SYSTEM TUMORS IN UGANDA
por: Katasi, Victoria, et al.
Publicado: (2023)

RARE-05. MOLECULAR HETEROGENEITY OF PEDIATRIC CHOROID PLEXUS CARCINOMAS
por: Zaytseva, Margarita, et al.
Publicado: (2023)

OTHR-09. CENTRAL DIABETES INSIPIDUS: A RARE UNREPORTED SIDE EFFECT OF TEMOZOLOMIDE IN PEDIATRICS
por: Kuo, Christopher, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q1hqhsa0n6voe9snmih9cr0okk